Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

That’s where personalized weight loss programs come in. They tailor recommendations to your unique needs, whether it’s ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

另外，全球减肥药需求也突然传来不好的信号。据美国制药巨头礼来最新发布的2024年全年业绩预期，预计公司糖尿病药物Mounjaro在第四季度贡献营收约35亿美元，低于市场预期的44亿美元；减肥药Zepbound贡献营收约19亿美元，也不及市场预期的22亿美元。

We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are ...

Three Motley Fool contributors believe they've identified healthcare stocks in the latter category. Here's why they think Eli ...

Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe obstructive sleep apnea.

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...